Vietnam Drug Maker Blames GMP Compliance, Ingredients For Price Rise
This article was originally published in PharmAsia News
Executive Summary
The head of a major biotechnology company in Vietnam blames the recent surge in the prices of vaccines on the cost of imported ingredients and compliance with government regulations. Nguyen Thu Van, director of Vaccine and Bio-Technology Products Co. No. 1, said the cost of being a Good Manufacturing Practice company is part of the reason for the high costs of vaccines. Van said her firm has just submitted its first proposal to the government for a price increase in a year, with some of the vaccines to rise as much as 10 percent. (Click here for more